RD

Roopwati Dangi

Active Director Director DIN 09786942
DIN 09786942 First appointment Nov 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Roopwati Dangi

Data last updated:

Roopwati Dangi is a Director at Willchem Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Willchem Pharmaceutical Private Limited reported revenue of ₹4.3 Lakh (FY 2025).

DIN 09786942
Primary Designation Director
Industry Pharma
First Appointment 10 Nov 2022
Oldest Company Age 3 yrs
Largest company Willchem Pharmaceutical Private Limited · ₹4.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Nov 20222022₹4.3 Lakh (FY 2025)Active

Board colleagues of Roopwati Dangi

NameDINCompanyDesignation
Rajendra Dangi09786941Willchem Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Willchem Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Roopwati Dangi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roopwati Dangi

Roopwati Dangi currently holds 1 directorship: Willchem Pharmaceutical Private Limited (Director, since 10 Nov 2022, revenue ₹4.3 Lakh (FY 2025)).

Roopwati Dangi was first appointed on 10 Nov 2022 as Director at Willchem Pharmaceutical Private Limited.

The current boards of Roopwati Dangi's companies include Rajendra Dangi (Willchem Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available